High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen

A S Freedman, D Neuberg, J G Gribben, P Mauch, R J Soiffer, D C Fisher, K C Anderson, N Andersen, R Schlossman, M Kroon, J Ritz, J Aster, L M Nadler, High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Journal of Clinical Oncology. ,vol. 16, pp. 13- 18 ,(1998) , 10.1200/JCO.1998.16.1.13

Luis Fayad, Deborah Thomas, Jorge Romaguera, Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas. Clinical Lymphoma, Myeloma & Leukemia. ,vol. 8, ,(2007) , 10.3816/CLM.2007.S.034

Olaf Determann, Eva Hoster, German Ott, Heinz Wolfram Bernd, Christoph Loddenkemper, Martin Leo Hansmann, Thomas EF Barth, Michael Unterhalt, Wolfgang Hiddemann, Martin Dreyling, Wolfram Klapper, European Mantle Cell Lymphoma Network, German Low Grade Lymphoma Study Group, Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood. ,vol. 111, pp. 2385- 2387 ,(2008) , 10.1182/BLOOD-2007-10-117010

Marco Ladetto, Michele Magni, Gloria Pagliano, Federica De Marco, Daniela Drandi, Irene Ricca, Monica Astolfi, Paola Matteucci, Anna Guidetti, Barbara Mantoan, Chiara Lobetti Bodoni, Manuela Zanni, Mario Boccadoro, Alessandro M. Gianni, Corrado Tarella, Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma Biology of Blood and Marrow Transplantation. ,vol. 12, pp. 1270- 1276 ,(2006) , 10.1016/J.BBMT.2006.07.007

Christian H. Geisler, Arne Kolstad, Anna Laurell, Niels S. Andersen, Lone B. Pedersen, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiær, Måns Åkerman, Mats Ehinger, Christer Sundström, Ruth Langholm, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, , Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group Blood. ,vol. 112, pp. 2687- 2693 ,(2008) , 10.1182/BLOOD-2008-03-147025

Eva Hoster, Martin Dreyling, Wolfram Klapper, Christian Gisselbrecht, Achiel van Hoof, Hanneke C. Kluin-Nelemans, Michael Pfreundschuh, Marcel Reiser, Bernd Metzner, Hermann Einsele, Norma Peter, Wolfram Jung, Bernhard Wörmann, Wolf-Dieter Ludwig, Ulrich Dührsen, Hartmut Eimermacher, Hannes Wandt, Joerg Hasford, Wolfgang Hiddemann, Michael Unterhalt, A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma Blood. ,vol. 111, pp. 558- 565 ,(2006) , 10.1182/BLOOD-2007-06-095331

Thomas E. Witzig, Susan M. Geyer, Irene Ghobrial, David J. Inwards, Rafael Fonseca, Paul Kurtin, Stephen M. Ansell, Ronnie Luyun, Patrick J. Flynn, Roscoe F. Morton, Shaker R. Dakhil, Howard Gross, Scott H. Kaufmann, Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma Journal of Clinical Oncology. ,vol. 23, pp. 5347- 5356 ,(2005) , 10.1200/JCO.2005.13.466

Richard I. Fisher, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegovic, Michael J. Robertson, Sven de Vos, Elliot Epner, Amrita Krishnan, John P. Leonard, Sagar Lonial, Edward A. Stadtmauer, Owen A. O'Connor, Hongliang Shi, Anthony L. Boral, André Goy, Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma Journal of Clinical Oncology. ,vol. 24, pp. 4867- 4874 ,(2006) , 10.1200/JCO.2006.07.9665

Georg Lenz, Martin Dreyling, Eva Hoster, Bernhard Wörmann, Ulrich Dührsen, Bernd Metzner, Hartmut Eimermacher, Andreas Neubauer, Hannes Wandt, Hjalmar Steinhauer, Sonja Martin, Else Heidemann, Ali Aldaoud, Reza Parwaresch, Joerg Hasford, Michael Unterhalt, Wolfgang Hiddemann, Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG) Journal of Clinical Oncology. ,vol. 23, pp. 1984- 1992 ,(2005) , 10.1200/JCO.2005.08.133

AM Gianni, , S Cortelazzo, M Magni, M Martelli, Rituximab: enhancing stem cell transplantation in mantle cell lymphoma. Bone Marrow Transplantation. ,vol. 29, ,(2002) , 10.1038/SJ.BMT.1703296